首站-论文投稿智能助手
典型文献
Lunasin protease inhibitor concentrate decreases pro-inflammatory cytokines and improves histopathological markers in dextran sodium sulfate-induced ulcerative colitis
文献摘要:
Lunasin protease inhibitor concentrate (LPIC) is a novel combination of soy bioactive peptide lunasin, Kunitz and Bowman-Birk protease inhibitors. The reported anti-inflammatory and anticancer properties of each one of them suggest LPIC as a promising candidate for the treatment of inflammatory-related diseases. Our objective was to assess the in vivo anti-inflammatory properties of LPIC. First, an in vitro test was performed in lipopolysaccharide (LPS)-activated RAW264.7 murine macrophages by measuring the production of nitric oxide (NO), interleukin-6 (IL-6), and tumor necrosis factor α (TNF-α) as inflammatory markers. For the in vivo model, ulcerative colitis (UC) was induced in mice via oral administration of dextran sodium sulfate (DSS). LPIC treatment was performed via daily intraperitoneal injection of 50 mg/kg body weight. Body weight, visible blood in stool and stool consistency were scored daily as macroscopic indicators of disease progression. Occult blood was evaluated by the presence of hemoglobin in stool every third day. Colon length, caecum weight, colonic myeloperoxidase activity (MPO), presence of pro-inflammatory cytokines in blood and colon, changes in the architecture, and expression of inducible nitric oxide synthase (iNOS) in colonic tissue were evaluated. In vitro, LPIC induced production of NO and maintained cytokine levels in comparison to activated untreated macrophages. In vivo, LPIC increased colonic bleeding and did not improve macroscopic markers of the disease, but reduced colonic IL-1β and IL-6, decreased systemic circulation of TNF-α, attenuated neutrophils infiltration and iNOS expression in colonic tissue, and diminished the damage in colonic architecture. Our results suggest that combinations of peptides in LPIC may counteract the anti-inflammatory properties in vitro; while in vivo, LPIC can significantly reduce the histopathological damage, hence is a possible therapeutic strategy to attenuate UC.
文献关键词:
作者姓名:
Andrea Nieto-Veloza;Zhihong Wang;Qixin Zhong;Doris D'Souza;Hari B.Krishnan;Vermont P.Dia
作者机构:
Department of Food Science,University of Tennessee,Knoxville 37996,USA;Agricultural Research Service,USDA,Columbia 65211,USA
引用格式:
[1]Andrea Nieto-Veloza;Zhihong Wang;Qixin Zhong;Doris D'Souza;Hari B.Krishnan;Vermont P.Dia-.Lunasin protease inhibitor concentrate decreases pro-inflammatory cytokines and improves histopathological markers in dextran sodium sulfate-induced ulcerative colitis)[J].食品科学与人类健康(英文),2022(06):1508-1514
A类:
Lunasin,LPIC,lunasin,Birk,Occult
B类:
protease,concentrate,decreases,inflammatory,cytokines,improves,histopathological,markers,dextran,sodium,sulfate,induced,ulcerative,colitis,novel,soy,bioactive,Kunitz,Bowman,inhibitors,reported,anticancer,properties,each,them,suggest,promising,candidate,treatment,related,diseases,Our,objective,was,assess,vivo,First,vitro,test,performed,lipopolysaccharide,LPS,activated,RAW264,murine,macrophages,by,measuring,production,nitric,oxide,interleukin,tumor,necrosis,For,model,UC,mice,via,oral,administration,DSS,daily,intraperitoneal,injection,body,weight,Body,visible,blood,stool,consistency,were,scored,macroscopic,indicators,progression,evaluated,presence,hemoglobin,every,third,day,Colon,length,caecum,colonic,myeloperoxidase,activity,MPO,changes,architecture,expression,inducible,synthase,iNOS,tissue,In,maintained,levels,comparison,untreated,increased,bleeding,not,but,reduced,decreased,systemic,circulation,attenuated,neutrophils,infiltration,diminished,damage,results,that,combinations,peptides,may,counteract,while,significantly,hence,possible,therapeutic,strategy
AB值:
0.476381
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis
Xingyan Zhang;Xiaoyan Lian;Huling Li;Wenjing Zhao;Xin Li;Fujun Zhou;Yutong Zhou;Tao Cui;Yuli Wang;Changxiao Liu-Key Laboratory of Quality-marker of Traditional Chinese Medicines,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;Department of Pharmacology,Tianjin Medical University,Tianjin 300070,China;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Key Laboratory of Systems Bioengineering(Ministry of Education),School of Chemistry Engineering and Technology,Tianjin University,Tianjin 300072,China;Pharmaceuticai Armaceuticai DA REN TANG Group Corporation Limited Traditional Chinese Pharmacy Researchinstitute,Tianjin 300457,China;Tianjin Key Laboratory of Quality Control in Chinese Medicine,Tianjin 300457,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Beijing 100730,China
A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1β and IL-6
Liping Liao;Wenzhen Dang;Tingting Lin;Jinghua Yu;Tonghai Liu;Wen Li;Senhao Xiao;Lei Feng;Jing Huang;Rong Fu;Jiacheng Li;Liping Liu;Mingchen Wang;Hongru Tao;Hualiang Jiang;Kaixian Chen;Xingxing Diao;Bing Zhou;Xiaoyan Shen;Cheng Luo-State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Pharmacology&the Key Laboratory of Smart Drug Delivery,Ministry of Education,School of Pharmacy,Fudan University,Shanghai 201203,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,University of Chinese Academy of Sciences,Hangzhou 310024,China;School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China
CDDO-Im ameliorates osteoarthritis and inhibits chondrocyte apoptosis in mice via enhancing Nrf2-dependent autophagy
Jian Dong;Kai-jia Zhang;Gao-cai Li;Xing-ren Chen;Jia-jia Lin;Jia-wei Li;Zhong-yang Lv;Zhao-zhi Deng;Jin Dai;Wangsen Cao;Qing Jiang-Division of Sports Medicine and Adult Reconstructive Surgery,Department of Orthopedic Surgery,State Key Laboratory of Pharmaceutical Biotechnology,Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,China;Department of Orthopedics,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Critical Care Medicine,Jinling Hospital,School of Medicine,Nanjing University Medical School,Nanjing 210003,China;Center for Organ Fibrosis and Remodeling Research,Jiangsu Key Lab of Molecular Medicine,Nanjing University Medical School,Nanjing 210093,China
GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages
Qing Zhang;Lin-hai Chen;Hui Yang;You-chen Fang;Si-wei Wang;Min Wang;Qian-ting Yuan;Wei Wu;Yang-ming Zhang;Zhan-ju Liu;Fa-jun Nan;Xin Xie-State Key Laboratory of Drug Research,The National Center for Drug Screening,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,University of Chinese Academy of Sciences,Hangzhou 310024,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Gastroenterology,The Shanghai Tenth People's Hospital,Tongji University,Shanghai 200072,China;Burgeon Therapeutics Co.,Ltd,Shanghai 201203,China;Yantai Key Laboratory of Nanomedicine and Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。